A Pan-TB Regimen Targeting Host and Microbe

Condition:   Tuberculosis Interventions:   Drug: Sutezolid;   Drug: N-acetyl cysteine;   Drug: Pretomanid;   Drug: Bedaquiline;   Combination Product: Rifafour Sponsors:   The Aurum Institute NPC;   Ludwig-Maximilians - University of Munich;   Stichting Katholieke Universiteit;   Wits Health Consortium (Pty) Ltd;   Instituto Nacional de Saúde, Mozambique;   National Institute for Medical Research, Tanzania;   University of Stellenbos ch;   Sequella, Inc.;   Global Alliance for TB Drug Development Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials